PET-CT for Assessment of Multiple Myeloma Disease Burden and Metabolic Response before and after Carfilzomib-Based Induction, Consolidation and Carfilzomib Maintenance Therapy: Data from the UK NCRI Cardamon Study
Ceri Bygrave(Cardiff and Vale University Health Board), Kwee Yong(CRUK Lung Cancer Centre of Excellence), Jonathan Sive(University College London Hospitals NHS Foundation Trust), Elizabeth H. Phillips(University of Manchester), Lucy Pike(King's College London), James D. Cavenagh(National Health Service), Tushhar Dadaga(Cancer Research UK), Laura Clifton‐Hadley(Cancer Research UK), Sally F. Barrington(King's College London), Matthew Streetly(King's College - North Carolina), Gavin Pang(Cancer Research UK), Roger G. Owen(Leeds Teaching Hospitals NHS Trust), Lydia Eccersley(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo), Manil Subesinghe, Karthik Ramasamy(Oxford University Hospitals NHS Trust), Richard G. Jenner(Cancer Research UK), Michael A. Chapman(Toronto Metropolitan University), Rakesh Popat(University College London Hospitals NHS Foundation Trust), Marquita Camilleri(University College London Hospitals NHS Foundation Trust), Sally Moore(University College Hospital), Sumaiya Kamora(Cancer Research UK), Selina J Chavda(University College London), Lalita Banerjee(Maidstone and Tunbridge Wells NHS Trust), Reuben Benjamin(King's College London), María Cuadrado(University College London), William Wilson(Cancer Research UK)
Cited by 0
Related Papers
High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple Myeloma
|New England Journal of Medicine|2003|1.8k
Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group
|Journal of Clinical Oncology|2014|1.6k
Teclistamab in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2022|1.2k